AnatomyDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureHumanitiesInformation ScienceNamed GroupsHealth CareGeographicals
Polycystic Ovary SyndromeClinical Trials as TopicHyperandrogenismHirsutismOligomenorrheaMetforminClinical Trials, Phase III as TopicDouble-Blind MethodAnovulationResearch DesignClinical Trials, Phase II as TopicInsulin ResistanceTreatment OutcomeClinical Trials, Phase I as TopicControlled Clinical Trials as TopicTestosteroneAndrogensInfertility, FemaleClomiphenePlacebosAndrostenedione17-alpha-HydroxyprogesteroneProspective StudiesSex Hormone-Binding GlobulinTime FactorsOvaryMenstruation DisturbancesFollow-Up StudiesBody Mass IndexPatient SelectionClinical ProtocolsDehydroepiandrosterone SulfateEarly Termination of Clinical TrialsSingle-Blind MethodHypoglycemic AgentsObesityInsulinLuteinizing HormoneMulticenter Studies as TopicAnti-Mullerian HormoneCase-Control StudiesOvulation InductionDrug Administration ScheduleClinical Trials Data Monitoring CommitteesDrug Therapy, CombinationCyproterone AcetatePregnancyPilot ProjectsRisk FactorsAcne VulgarisFertility Agents, FemaleBlood GlucoseQuality of LifeFollicle Stimulating HormoneMenstrual CycleSample SizeCost-Benefit AnalysisAntineoplastic Combined Chemotherapy ProtocolsGlucose Tolerance TestHyperinsulinismClinical Trials, Phase IV as TopicOvulationBiological MarkersHormonesAmenorrheaAdministration, OralOutcome Assessment (Health Care)NeoplasmsLive BirthPregnancy RateQuestionnairesAntineoplastic AgentsCombined Modality TherapyDose-Response Relationship, DrugSeverity of Illness IndexSurvival AnalysisCohort StudiesPatient ComplianceOverweightGonadotropinsEthinyl EstradiolRecurrenceUnited StatesCross-Over StudiesIntention to Treat AnalysisFertilization in VitroEvidence-Based MedicineCardiovascular DiseasesDietary SupplementsAnalysis of VarianceDisease-Free SurvivalSteroid 17-alpha-HydroxylaseFollicular FluidFeasibility StudiesExercise TherapyRandom AllocationRisk AssessmentOvarian FollicleResearch SubjectsSurvival Rate